Associate Consultants

Mr Assad Jalil


Mr. Assad Jalil is a Consultant Ophthalmologist, Vitreoretinal and Cataract Surgeon and Uveitis Specialist at Manchester Royal Eye Hospital, one of the leading ophthalmic units of Europe, and a centre for clinical and research excellence.
Mr. Jalil has extensive experience in all aspects of latest vitreoretinal surgery including 23G, 25G and 27G pars plana vitrectomies. He has a special interest in surgical and medical management of vitreous and retinal diseases including retinal detachment; diabetic retinopathy; macular diseases including macular hole and epiretinal membranes; floaters; retinal vein occlusions; and age-related macular degeneration (including the use of intravitreal anti-VEGF injections). His surgical expertise also encompasses simple and complex cataract surgery as well as dealing with complications of cataract surgery. In addition, he is an expert of complex, sight- threatening ocular inflammatory disorders (uveitis) especially in the use of immunosuppressive medications and vitrectomy in dealing with this condition. He regularly audits his practice to ensure the highest standards of quality of care.

In addition to his clinical expertise, Mr. Jalil is an integral part of the research team at Manchester Royal Eye Hospital which has pioneered research into, amongst others, retinal implants and retinal gene therapy. He is one of the few retinal surgeons in the world performing retinal gene therapy and recently carried out one of the first ocular gene therapy surgeries in UK on a patient with a rare inherited retinal disease.

Mr. Jalil has co-authored 3 book chapters in addition to more than 30 publications in peer-reviewed ophthalmic journals. He regularly presents at national and international meetings. He is the supervisor of the well renowned Clinical as well as the Research Vitreoretinal fellowships at Manchester Royal Eye Hospital, and is involved in training surgeons from all over the world.

Mr Conrad Yuen

MB ChB (Liverpool) MRCOphth (London) FRCS (Edinburgh)

Mr Conrad Yuen is a consultant ophthalmologist with a special interest in glaucoma. He is the leading glaucoma consultant at Stepping Hill Hospital in Stockport for the past 12 years. He was also the Clinical Director for Ophthalmology between 2012-2018.

Originally from Hong Kong, Mr Yuen came to attend boarding school in the UK in 1984. After graduating from Liverpool Medical School in 1994 with commendation, Mr Yuen chose a career in Ophthalmology and got his first junior post in Glasgow in 1995. He then joined Mersey’s training scheme in 1998. He completed his Higher Surgical Training in 2008.

Despite being eligible for a general consultant’s post, Mr Yuen decided to further specialise in glaucoma care and was fortunate enough to earn a Glaucoma Fellowship at Moorfields Eye Hospital in London in 2008. He completed an extra year of glaucoma training and in 2009, he became Stepping Hill Hospital’s glaucoma lead consultant. He succeeded in aligning glaucoma care with NICE guidelines locally.

Apart from being a very experienced cataract surgeon, he has built vast experience in glaucoma surgeries, including modern trabeculectomy, glaucoma tube surgery, laser treatments like peripheral iridotomy, selective laser trabeculoplasty and cyclodiode laser ciliary body ablation. Mr Yuen has also introduced the latest stent surgery (Minimally Invasive Glaucoma surgery MIGs) to Stockport.

Mr Yuen’s research interests include glaucoma care delivery in our healthcare system, efficient use of resources and enhancing patient safety. His publications in peer-reviewed journals include subjects relating to glaucoma care post NICE, utilisation of electronic records in glaucoma care and capsular opacification after cataract surgery. He is involved in training junior doctors, opticians and nurse practitioners. Mr Yuen is passionate about holistic glaucoma care and patient education too. He has chaired glaucoma patient support group meetings in Buxton for over 10 years.

© Copyright - Lavin de Klerk & Associates Eye Clinic | GDPR